Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001907345-25-000006
Filing Date
2025-11-12
Accepted
2025-11-12 20:33:30
Documents
1
Period of Report
2025-11-10

Document Format Files

Seq Description Document Type Size
1 form4-11132025_011126.html 4  
1 form4-11132025_011126.xml 4 3329
  Complete submission text file 0001907345-25-000006.txt   4751
Mailing Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 650 695-0677
Lyell Immunopharma, Inc. (Issuer) CIK: 0001806952 (see all company filings)

EIN.: 833006753 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O LYELL IMMUNOPHARMA, INC. 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080
Business Address
Lee Gary K. (Reporting) CIK: 0001907345 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40502 | Film No.: 251475035